Botulinum Toxin Assay With Improved Sensitivity

Patent No. EP3030905 (titled "Botulinum Toxin Assay With Improved Sensitivity") was filed by Biomadison on Aug 8, 2014. The application was issued on Apr 3, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MERZ PHARMAJun 28, 2018ALTMANN STOSSEL DICK PATENTANWALTE PARTG MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3030905

BIOMADISON
Application Number
EP14761444A
Filing Date
Aug 8, 2014
Status
Patent Maintained As Amended
Dec 8, 2023
Publication Date
Apr 3, 2024